BriaCell Therapeutics Financial Overview
BriaCell Therapeutics's market cap is currently C$17.08M. The company's EPS TTM is $-4.383606114; its P/E ratio is -0.19; BriaCell Therapeutics is scheduled to report earnings on December 11, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
